Announcements Trials
Browse Landscape

Phase

Phase 2 64Phase 3 27Phase 1 15Phase NA 7Phase 1/2 7Phase 2/3 6Phase EARLY_PHASE1 1Phase 4 1

Status

Completed 1

Sponsor Class

OTHER 51INDUSTRY 14OTHER_GOV 3NETWORK 1FED 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Pleural Effusion, Malignant 1Ovarian Cysts 1Mycosis Fungoides 1Multiple Myeloma 1Lymphoma, T-Cell, Cutaneous 1Lymphoma, Non-Hodgkin 1Lung Neoplasms 1Long Qt Syndrome 3 1Localized Advanced Rectal Adenocarcinoma 1Leukemia, Myeloid, Acute 1Kidney Neoplasms 1Infertility 1Hodgkin Disease 1Endometriosis 1Carcinoma, Non-Small-Cell Lung 1

Interventions

Docetaxel 1Carboplatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 4 × NETWORK × Lung Neoplasms × Clear all
NCT00883675 2013-12-18

Safety Study of Adjuvant Docetaxel-Carboplatin Treatment for Resected Lung Cancer

Maestro Clinical, Inc.

Phase 4 Completed
133 enrolled 8 charts
Thoracic

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡